Nasdaq Panel to delist biote Corp. on July 20; company plans appeal and OTC Pink Market trading

biote Corp.

Nasdaq Panel determined to delist BTMD Class A common stock and warrants for non-compliance with Round Lot Holder and Market Value of Unrestricted Publicly Held Shares requirements.
Trading suspended effective July 20, 2022; company expects to trade on OTC Pink Market pending appeal.
Company believes it will meet both listing requirements by July 19 and intends to appeal to Nasdaq Listing and Hearing Review Council.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.